We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Positively Charged Anticancer Nanoparticles Accumulate in the Acidic Microenvironment of a Tumor

By LabMedica International staff writers
Posted on 24 Jul 2013
Nanoparticles containing an anticancer drug within a weak polybase sphere accumulate inside tumors where the acidic environment promotes their retention and induces swelling, which enhances delivery of the chemotherapeutic load.

Investigators at Purdue University (West Lafayette, IN, USA) coined the term "pH phoresis" to describe the tendency of nanoparticles composed of weak polybases (such as polyamines) to migrate to areas of negative charge when exposed to a pH gradient.

Furthermore, in regions of lower pH—such as in the pH 6.5-6.9 microenvironment surrounding a tumor—increased protonation of the amines in the shell cause them to repel each other, which forces the particles to expand in size. Doubling the size of the particles would, in theory, result in a similar increase in the efficiency of drug delivery to tumors.

"This phenomenon, which we term pH phoresis, may provide a useful mechanism for improving the delivery of drugs to cancer cells in solid tumor tissues," said first author Dr. You-Yeon Won, associate professor of chemical engineering at Purdue University. "Such an effect would be a game changer by delivering the proper dose of anticancer drugs inside tumor cells. This pH phoresis concept also could be combined readily within other established drug-delivery methodologies, making it potentially practical for medical application."

Related Links:
Purdue University




Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Manual Pipetting Aid
Pipette Controllers macro

Latest BioResearch News

Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers
24 Jul 2013  |   BioResearch

Lysosomal Gene Defect Linked to Severe Childhood Brain Disorders
24 Jul 2013  |   BioResearch

Genetic Testing Identifies Greater Inherited Sudden Cardiac Arrest Risk in Younger Individuals
24 Jul 2013  |   BioResearch



ADLM